Nitric oxide synthase uncoupling: A therapeutic target in cardiovascular diseases

Vascular Pharmacology

Volumn 57, Issue 5-6, 2012, Pages 168-172

  Roe, Nathan D ^a   Ren, Jun ^a  

^a UNIVERSITY OF WYOMING COLLEGE OF HEALTH SCIENCES   (United States)

Author keywords

Cardiovascular; NOS; Oxidative stress; Uncoupling

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; ACETYLCYSTEINE; ADENYLATE CYCLASE; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ASCORBIC ACID; CALCIUM; CYCLIC GMP; DIHYDROFOLATE REDUCTASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FOLIC ACID; GUANYLATE CYCLASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REGULATOR PROTEIN; SUPEROXIDE; TETRAHYDROBIOPTERIN; XANTHINE OXIDASE;

ATHEROSCLEROSIS; BIOAVAILABILITY; CALCIUM CELL LEVEL; CARDIOVASCULAR DISEASE; CONGESTIVE CARDIOMYOPATHY; DIABETES MELLITUS; DIASTOLIC DYSFUNCTION; DRUG EFFICACY; DRUG TARGETING; ENDOTHELIAL DYSFUNCTION; EXCITATION CONTRACTION COUPLING; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; NITROSYLATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PHENYLKETONURIA; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; VASODILATATION;

ANIMALS; ARGININE; CALCIUM; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS;

EID: 84864800398     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2012.02.004     Document Type: Review

References (60)

1. Adak S., Santolini J., Tikunova S., et al. Neuronal nitric-oxide synthase mutant (Ser-1412→Asp) demonstrates surprising connections between heme reduction, NO complex formation, and catalysis. J. Biol. Chem. 2001, 276(2):1244-1252.
2. Alp N.J., Channon K.M. Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arterioscler. Thromb. Vasc. Biol. 2004, 24(3):413-420.
3. Antoniades C., Shirodaria C., Warrick N., et al. 5-Methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling. Circulation 2006, 114(11):1193-1201.
4. Barouch L.A., Harrison R.W., Skaf M.W., et al. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 2002, 416(6878):337-339.
5. Berkowitz D.E., White R., Li D., et al. Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation 2003, 108(16):2000-2006.
6. Cai S., Khoo J., Channon K.M. Augmented BH4 by gene transfer restores nitric oxide synthase function in hyperglycemic human endothelial cells. Cardiovasc. Res. 2005, 65(4):823-831.
7. Ceylan-Isik A.F., Guo K.K., Carlson E.C., et al. Metallothionein abrogates GTP cyclohydrolase I inhibition-induced cardiac contractile and morphological defects: role of mitochondrial biogenesis. Hypertension 2009, 53(6):1023-1031.
8. Chalupsky K., Cai H. Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(25):9056-9061.
9. Chen C.A., Druhan L.J., Varadharaj S., et al. Phosphorylation of endothelial nitric-oxide synthase regulates superoxide generation from the enzyme. J. Biol. Chem. 2008, 283(40):27038-27047.
10. Chen C.A., Wang T.Y., Varadharaj S., et al. S-glutathionylation uncouples eNOS and regulates its cellular and vascular function. Nature 2010, 468(7327):1115-1118.
11. Clancy R.M., Leszczynska-Piziak J., Abramson S.B. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J. Clin. Invest. 1992, 90(3):1116-1121.
12. de Belder A.J., Radomski M.W., Why H.J., et al. Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy but not in ischaemic or valvar heart disease. Br. Heart J. 1995, 74(4):426-430.
13. Dumitrescu C., Biondi R., Xia Y., et al. Myocardial ischemia results in tetrahydrobiopterin (BH4) oxidation with impaired endothelial function ameliorated by BH4. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(38):15081-15086.
14. Francis S.H., Busch J.L., Corbin J.D., et al. cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacol. Rev. 2010, 62(3):525-563.
15. Franscini N., Bachli E.B., Blau N., et al. Functional tetrahydrobiopterin synthesis in human platelets. Circulation 2004, 110(2):186-192.
16. Gao L., Chalupsky K., Stefani E., et al. Mechanistic insights into folic acid-dependent vascular protection: dihydrofolate reductase (DHFR)-mediated reduction in oxidant stress in endothelial cells and angiotensin II-infused mice: a novel HPLC-based fluorescent assay for DHFR activity. J. Mol. Cell. Cardiol. 2009, 47(6):752-760.
17. Gonzalez D.R., Beigi F., Treuer A.V., et al. Deficient ryanodine receptor S-nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytes. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(51):20612-20617.
18. Gonzalez D.R., Treuer A., Sun Q.A., et al. S-nitrosylation of cardiac ion channels. J. Cardiovasc. Pharmacol. 2009, 54(3):188-195.
19. Ignarro L.J. Signal transduction mechanisms involving nitric oxide. Biochem. Pharmacol. 1991, 41(4):485-490.
20. Ignarro L.J. Physiology and pathophysiology of nitric oxide. Kidney Int. Suppl. 1996, 55:S2-S5.
21. Jo H., Otani H., Jo F., et al. Inhibition of nitric oxide synthase uncoupling by sepiapterin improves left ventricular function in streptozotocin-induced diabetic mice. Clin. Exp. Pharmacol. Physiol. 2011, 38(8):485-493.
22. Kaneko M., Matsumoto Y., Hayashi H., et al. Oxygen free radicals and calcium homeostasis in the heart. Mol. Cell. Biochem. 1994, 139(1):91-100.
23. Kashiwagi A., Shinozaki K., Nishio Y., et al. Endothelium-specific activation of NAD(P)H oxidase in aortas of exogenously hyperinsulinemic rats. Am. J. Physiol. 1999, 277(6 Pt 1):E976-E983.
24. Kim Y.M., Bergonia H., Lancaster J.R. Nitrogen oxide-induced autoprotection in isolated rat hepatocytes. FEBS Lett. 1995, 374(2):228-232.
25. Kim J.H., Bugaj L.J., Oh Y.J., et al. Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats. J. Appl. Physiol. 2009, 107(4):1249-1257.
26. Layland J., Li J.M., Shah A.M. Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes. J. Physiol. 2002, 540(Pt 2):457-467.
27. Lima B., Forrester M.T., Hess D.T., et al. S-nitrosylation in cardiovascular signaling. Circ. Res. 2010, 106(4):633-646.
28. Lin M.I., Fulton D., Babbitt R., et al. Phosphorylation of threonine 497 in endothelial nitric-oxide synthase coordinates the coupling of l-arginine metabolism to efficient nitric oxide production. J. Biol. Chem. 2003, 278(45):44719-44726.
29. Masano T., Kawashima S., Toh R., et al. Beneficial effects of exogenous tetrahydrobiopterin on left ventricular remodeling after myocardial infarction in rats: the possible role of oxidative stress caused by uncoupled endothelial nitric oxide synthase. Circ. J. 2008, 72(9):1512-1519.
30. Moens A.L., Champion H.C., Claeys M.J., et al. High-dose folic acid pretreatment blunts cardiac dysfunction during ischemia coupled to maintenance of high-energy phosphates and reduces postreperfusion injury. Circulation 2008, 117(14):1810-1819.
31. Moens A.L., Takimoto E., Tocchetti C.G., et al. Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin: efficacy of recoupling nitric oxide synthase as a therapeutic strategy. Circulation 2008, 117(20):2626-2636.
32. Mount P.F., Kemp B.E., Power D.A. Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation. J. Mol. Cell. Cardiol. 2007, 42(2):271-279.
33. Nagareddy P.R., Soliman H., Lin G., et al. Selective inhibition of protein kinase C beta(2) attenuates inducible nitric oxide synthase-mediated cardiovascular abnormalities in streptozotocin-induced diabetic rats. Diabetes 2009, 58(10):2355-2364.
34. Nishijima Y., Sridhar A., Bonilla I., et al. Tetrahydrobiopterin depletion and NOS2 uncoupling contribute to heart failure-induced alterations in atrial electrophysiology. Cardiovasc. Res. 2011, 91(1):71-79.
35. Okazaki T., Otani H., Shimazu T., et al. Reversal of inducible nitric oxide synthase uncoupling unmasks tolerance to ischemia/reperfusion injury in the diabetic rat heart. J. Mol. Cell. Cardiol. 2011, 50(3):534-544.
36. Oudot A., Vergely C., Ecarnot-Laubriet A., et al. Angiotensin II activates NADPH oxidase in isolated rat hearts subjected to ischaemia-reperfusion. Eur. J. Pharmacol. 2003, 462(1-3):145-154.
37. Poteser M., Romanin C., Schreibmayer W., et al. S-nitrosation controls gating and conductance of the alpha 1 subunit of class C l-type Ca(2+) channels. J. Biol. Chem. 2001, 276(18):14797-14803.
38. Ren J., Duan J., Thomas D.P., et al. IGF-I alleviates diabetes-induced RhoA activation, eNOS uncoupling, and myocardial dysfunction. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 294(3):R793-R802.
39. Roe N.D., Thomas D.P., Ren J. Inhibition of NADPH oxidase alleviates experimental diabetes-induced myocardial contractile dysfunction. Diabetes Obes. Metab. 2011, 13(5):465-473.
40. Santhanam L., Lim H.K., Lim H.K., et al. Inducible NO synthase dependent S-nitrosylation and activation of arginase1 contribute to age-related endothelial dysfunction. Circ. Res. 2007, 101(7):692-702.
41. Schafer A., Alp N.J., Cai S., et al. Reduced vascular NO bioavailability in diabetes increases platelet activation in vivo. Arterioscler. Thromb. Vasc. Biol. 2004, 24(9):1720-1726.
42. Sears C.E., Bryant S.M., Ashley E.A., et al. Cardiac neuronal nitric oxide synthase isoform regulates myocardial contraction and calcium handling. Circ. Res. 2003, 92(5):e52-e59.
43. Shi W., Meininger C.J., Haynes T.E., et al. Regulation of tetrahydrobiopterin synthesis and bioavailability in endothelial cells. Cell Biochem. Biophys. 2004, 41(3):415-434.
44. Shimazu T., Otani H., Yoshioka K., et al. Sepiapterin enhances angiogenesis and functional recovery in mice after myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 2011, 301(5):H2061-H2072.
45. Silberman G.A., Fan T.H., Liu H., et al. Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction. Circulation 2010, 121(4):519-528.
46. Singal P.K., Khaper N., Palace V., et al. The role of oxidative stress in the genesis of heart disease. Cardiovasc. Res. 1998, 40(3):426-432.
47. Soro-Paavonen A., Watson A.M., Li J., et al. Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes. Diabetes 2008, 57(9):2461-2469.
48. Stamler J.S., Simon D.I., Osborne J.A., et al. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc. Natl. Acad. Sci. U. S. A. 1992, 89(1):444-448.
49. Sugamura K., Keaney J.F. Reactive oxygen species in cardiovascular disease. Free Radic. Biol. Med. 2011, 51(5):978-992.
50. Takimoto E., Champion H.C., Li M., et al. Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load. J. Clin. Invest. 2005, 115(5):1221-1231.
51. Tsai E.J., Kass D.A. Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics. Pharmacol. Ther. 2009, 122(3):216-238.
52. van Etten R.W., de Koning E.J., Verhaar M.C., et al. Impaired NO-dependent vasodilation in patients with type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate. Diabetologia 2002, 45(7):1004-1010.
53. Vila-Petroff M.G., Younes A., Egan J., et al. Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes. Circ. Res. 1999, 84(9):1020-1031.
54. Wenzel P., Schulz E., Oelze M., et al. AT1-receptor blockade by telmisartan upregulates GTP-cyclohydrolase I and protects eNOS in diabetic rats. Free Radic. Biol. Med. 2008, 45(5):619-626.
55. Wink D.A., Miranda K.M., Espey M.G., et al. Mechanisms of the antioxidant effects of nitric oxide. Antioxid. Redox Signal. 2001, 3(2):203-213.
56. 2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. J. Biol. Chem. 1998, 273(40):25804-25808.
57. Zhang M., Shah A.M. Role of reactive oxygen species in myocardial remodeling. Curr. Heart Fail. Rep. 2007, 4(1):26-30.
58. Zheng J.S., Yang X.Q., Lookingland K.J., et al. Gene transfer of human guanosine 5'-triphosphate cyclohydrolase I restores vascular tetrahydrobiopterin level and endothelial function in low renin hypertension. Circulation 2003, 108(10):1238-1245.
59. Zhou L., Zhu D.Y. Neuronal nitric oxide synthase: structure, subcellular localization, regulation, and clinical implications. Nitric Oxide 2009, 20(4):223-230.
60. Zou M.H., Shi C., Cohen R.A. Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J. Clin. Invest. 2002, 109(6):817-826.